Gatifloxacin derivative and preparation method and application thereof

A technology of compounds and nitrogen oxides, which can be used in drug combinations, pharmaceutical formulations, medical preparations containing active ingredients, etc., and can solve problems such as abnormal blood sugar

Active Publication Date: 2018-02-23
SOUTHWEST UNIVERSITY
View PDF3 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, it was found clinically that gatifloxacin can cause severe abnormal blood sugar,

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gatifloxacin derivative and preparation method and application thereof
  • Gatifloxacin derivative and preparation method and application thereof
  • Gatifloxacin derivative and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example 1

[0083] Preparation Example 1: Preparation of IM1

[0084] Add GAT 5mmol, DCM 15mL, NaHCO 3 7.5 mmol, after stirring evenly, slowly add 2.5 mmol of solid phosgene in 5 mL of dichloromethane (DCM) dropwise under ice bath. After the dropwise addition, move to room temperature to stir the reaction, and monitor the reaction progress by TLC. After the reaction was completed, 10 mL of ice-cold saturated NaCl solution was added, and 2N HCl solution was added to adjust the pH value to 4-5, and the liquids were separated. Saturated NaCl solution 10mL washed, separated, organic phase anhydrous NaCl 2 SO 4 After drying, the solvent was removed by rotary evaporation to obtain the pure product IM1.

preparation example 2

[0085] Preparation Example 2: Preparation of IM2

[0086] Into a 100mL round bottom flask, add raw materials GAT 1mmol, NaHCO 3 2.5mmol, DCM 5mL, add dropwise a mixed solution of chloroacetyl chloride 2mmol and DCM 2mL under ice-cooling. After dropping, the reaction was continuously stirred under ice bath, and the reaction progress was monitored by TLC. After the reaction, add a little ice-cold saturated NaCl solution to dissolve the solid, adjust the pH to 4-5 with ice-cold 2N HCl solution, stir evenly, transfer to a separatory funnel for liquid separation, extract twice with DCM, combine the organic phases, and wash with saturated NaCl solution. Water Na 2 SO 4 Dry and remove the solvent by rotary evaporation. The pure product was obtained by recrystallization or column chromatography, dried and weighed to obtain IM2. Preparation Example 3: Preparation of IM3

preparation example 3

[0087] Into a 100mL round bottom flask, add raw materials GAT 1mmol, NaHCO 3 2.5mmol, DCM 5mL, add dropwise a mixed solution of chloropropionyl chloride 2mmol and DCM 2mL under ice-cooling. After dropping, the reaction was continuously stirred under ice bath, and the reaction progress was monitored by TLC. After the reaction, add a little ice-cold saturated NaCl solution to dissolve the solid, adjust the pH to 4-5 with ice-cold 2N HCl solution, stir evenly, transfer to a separatory funnel for liquid separation, extract twice with DCM, combine the organic phases, and wash with saturated NaCl solution. Water Na 2 SO 4 Dry and remove the solvent by rotary evaporation. The pure product was obtained by recrystallization or column chromatography, dried and weighed to obtain IM3. Preparation Example 4: Preparation of IM4

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the chemical field of medicines, and particularly relates to a gatifloxacin derivative and a preparation method and application thereof. A gatifloxacin 7-side chain is subjected to structural modification to obtain a compound shown in a formula I. According to the compound disclosed by the invention, infection caused by mycobacterium tuberculosis and common bacteria can betreated, and the compound also has an inhibitory activity on bacteria persisters, citrus pathogens, nicotinamide N-methyltransferase (NNMT), interleukin IL-17 PPI and proprotein convertase subtilysin9 (PCSK9). The preparation process of the compound has the advantages that the operation is convenient, the condition is moderate, numerous compounds which has the advantages that the antibacterial activity is enhanced, the water solubility is improved and the toxic and side effect is lowered are obtained, the dosage of medicines is expected to be lowered, a treatment period is shortened, patientcompliance is improved, and a new molecular type and research thought can be provided for the research of tuberculosis medicines and other diseases.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry, and in particular relates to a gatifloxacin derivative and its preparation method and application. Background technique [0002] Tuberculosis (TB) is a chronic infectious disease mainly transmitted by respiratory tract caused by Mycobacterium tuberculosis (MTB). Mycobacterium tuberculosis mainly causes tuberculosis, and can also affect all other organs of the human body. It is one of the major diseases that seriously endanger human health, and it is also a long-term global public health and social problem of common concern. During the administration of anti-tuberculosis drugs, due to unreasonable treatment regimens and other reasons, the gene mutation of Mycobacterium tuberculosis occurs, and drug-resistant tuberculosis (DR-TB), especially multi-drug-resistant tuberculosis, is gradually increasing. The prevalence of drug-resistant tuberculosis has even appeared in many countries and regions. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D215/56C07D401/12C07D417/12A61K31/496A61K31/5377A61P35/00A61P31/04A61P29/00A61P9/00A61P31/06A61P1/04A61P3/06A61P9/10
CPCC07D215/56C07D401/12C07D417/12Y02A50/30
Inventor 杨大成黄敏范莉冯计周刘文谢建平胡军华徐兴然张金坤郭思瑶龙艳玲刘晋宇牟希张泽朝段湘科付彬王帆
Owner SOUTHWEST UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap